Le Lézard

All about health

All about health

All news and actualities about products of the health industry, pharmaceutical products, medical research, medicine, discoveries, hospitals, viruses and epidemics.

Fil RSS
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

24 january 2022

07:30
Multiple AB-729 and AB-836 HBV clinical data readouts anticipated to guide future clinical development and regulatory strategies Complete IND-enabling studies for oral PD-L1 inhibitor, AB-101, for the treatment of HBV Complete IND-enabling studies...

07:30
STAR-LLD is believed to be the first continuously delivered immunomodulatory imide drug (IMiD) in development to expand the use of lenalidomide in multiple myeloma and become the first IMiD for CLLStarton has shown unprecedented efficacy and...

07:30
Advancements in methods notably FES (functional electrical stimulation) have driven new opportunities in disabling brain disorders particularly in stroke and traumatic brain injury. Gamification are increasingly...

07:29
RhoVac AB ("RhoVac") announces today, 24th January 2022, that the Canadian Intellectual Property Office ("CIPO") has issued a "Notice of Allowance", which means that it intends to grant RhoVac's patent application for RV001 (onilcamotide) cancer...

07:20
NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced the publication of preclinical data evaluating the company's lead asset NT-I7 (efineptakin alfa), a novel T cell amplifier, in mouse...

07:15
Five Canadian "heroes" received World Vision Heroes for Children awards for their commitment and passion in helping the world's most vulnerable girls and boys....

07:15
The newly published report titled "Global Continuous Glucose Monitoring (CGM) Sensors Market? By Trends, Industry Competition Analysis,  Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2028." features in-depth analysis and an extensive...

07:10
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was selected as a limited distribution partner for VYVGARTtm (efgartigimod alfa-fcab) by argenx SE. VYVGART was approved by the U.S....

07:05
Ionis Pharmaceuticals, Inc. , the leader in antisense therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to eplontersen, an investigational antisense medicine for the treatment of people...

07:03
NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedletm) technology detection for proteomics, genomics, and single-run experiment multi-omics applications has announced that it has signed a lease for a standalone building of 30,880 square...

07:02
Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its Phase 1b clinical trial of VK0214 in patients with X-linked...

07:00
CloudMD Software & Services Inc. ("CloudMD" or the "Company"), a healthcare technology company transforming the delivery of care, is providing an update on its subsidiary, VisionPros, which was acquired on June 23, 2021. The Company has been advised...

07:00
Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to disclose that as part of its intellectual property patent applications filed in early 2021 for AP-188...

07:00
Lantern Pharma , a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug discovery and development today announced that the U.S. Food...

07:00
Indiana University's Public Policy Institute (PPI) estimates that Bloomington, Indiana based Cook Medical's medical device manufacturing facility nearing completion at 38th & Sheridan in Indianapolis will have an estimated economic impact of $25.9...

07:00
MyBiotics Pharma Ltd, a clinical stage microbiome therapeutics company, today announced the successful completion of Phase I clinical trial of MBX-SD-202 whole microbiome treatment in healthy volunteers. MBX-SD-202 has been developed and manufactured...

07:00
BioLineRx Ltd. , a late clinical-stage biopharmaceutical Company focused on oncology, today announced that the Company has completed enrollment of the Phase 1/2a study of its innovative intratumoral cancer vaccine candidate, AGI-134, designed to...

07:00
The "Neurorehabilitation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Neurorehabilitation Devices Market to Reach US$2.1 Billion by the Year 2026 Growth in the global market is...

07:00
Gummy supplement manufacturer TopGum Industries, Ltd.  has begun construction of a new, $US30M, 11,000m2 plant 1.5 hours south of Tel Aviv. The facility, joining the company's existing production plant, is expected to be fully operated in mid-2023...

07:00
Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, and Cynthia Sirard, MD, Chief Medical Officer, will...

07:00
Lyra Therapeutics, Inc. , a clinical-stage therapeutics company leveraging its proprietary XTreotm platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today...

07:00
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for eltanexor, a novel oral, Selective...

07:00
Vision Path, Inc., the parent company that owns Hubble Contacts and ContactsCart, today announced the hiring of Elliot Baldini as Chief Marketing Officer. Baldini, who joins Hubble from the Massachusetts-based School of Rock, is the latest in a...

07:00
CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, highlights a new publication in the peer-reviewed journal, Annals of Thoracic and...

07:00
ID.me provided the following comments today. Statement from ID.me CEO and Founder, Blake Hall:"We are committed to ensuring everyone can verify their identity online and use it to access essential services. ID.me combines best-in-breed 1:1 face match...

07:00
Fulcrum Equity Partners ("Fulcrum") is pleased to announce the acquisition of Texas Endovascular Associates ("Texas Endovascular"). Texas Endovascular is a premier specialty physician practice within Interventional Radiology with a focus on women's...

07:00
CallonDoc, a healthcare provider that gives patients the ability to consult with experienced doctors from the comfort of their own homes, now offers at-home testing kits with free front-door delivery. Priced from $35-$50, the kits enable users to...

06:55
ANI Pharmaceuticals, Inc. (ANI or the Company) today announced the U.S. commercial availability of Purified Cortrophintm Gel (Repository Corticotropin Injection USP) 80 U/mL. The commercial launch of Cortrophin Gel, an adrenocorticotropic hormone...

06:50
Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck's New Drug Application (NDA) for gefapixant, the investigational,...

06:50
SQZ Biotechnologies Company , focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17